SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inogen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
[March 16, 2019]

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inogen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm


The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Inogen, Inc. ("Inogen" or "the Company") (NASDAQ: INGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between November 8, 2017 and February 26, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 6, 2019.

If you are a shareholder who suffered a loss, click here to participate.



We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA (News - Alert) 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.


According to the Complaint, the Company made false and misleading statements to the market. Inogen overstated the total addressable market ("TAM") for its portable oxygen concentrators, while also misstating the basis for its TAM calculations. The Company claimed that sales growth was based on an effective salesforce, when the growth was actually based on deceptive tactics used on an elderly client base. The Company's domestic growth was inflated and eroding other areas of its business. In fact, very little of Inogen's sales were from the more stable Medicare market. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Inogen, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.


[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy